Patents by Inventor Karolina Busson

Karolina Busson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chromatographic methods for purification of proteins from plasma
    Patent number: 11807666
    Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of proteins, such as Factor VIII, von Willebrand factor and Factor IX. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
    Type: Grant
    Filed: November 29, 2022
    Date of Patent: November 7, 2023
    Assignee: Cytiva BioProcess R&D AB
    Inventors: Martin Hall, Karolina Busson, Jean-Luc Maloisel, Helena Skoglar
  • Chromatographic Methods for Purification of Proteins from Plasma
    Publication number: 20230091082
    Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of proteins, such as Factor VIII, von Willebrand factor and Factor IX. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
    Type: Application
    Filed: November 29, 2022
    Publication date: March 23, 2023
    Inventors: Martin Hall, Karolina Busson, Jean-Luc Maloisel, Helena Skoglar
  • Chromatographic methods for purification of proteins from plasma
    Patent number: 11542300
    Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of plasmaproteins, such as Factor VIII, von Willebrand factor and Factor IX. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: January 3, 2023
    Assignee: Cytiva BioProcess R&D AB
    Inventors: Martin Hall, Karolina Busson, Jean-Luc Maloisel, Helena Skoglar
  • Separation matrices for purification of biological particles
    Patent number: 11285460
    Abstract: The invention discloses a separation matrix for purification of biological particles, comprising a plurality of particles having a porous core entity and a porous shell entity covering the core entity, wherein the core entity comprises at least 50 micromole/ml primary amines present on covalently attached ligands displaying at least two primary amines per ligand and the shell entity comprises less than 20 micromole/ml primary amines The invention further discloses a method of purifying biological particles and a method of manufacturing a separation matrix.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: March 29, 2022
    Assignee: CYTIVA BIOPROCESS R&D AB
    Inventors: Jean-Luc Maloisel, Karolina Busson, Karol Lacki, Bjorn Noren, Helena Skoglar
  • Method for Chromatography
    Publication number: 20180127460
    Abstract: The present invention relates to the field of chromatography. More closely, the invention relates to a chromatographic method for purification of plasmaproteins, such as Factor VIII, von Willebrand factor and Factor IX. The chromatographic method is performed on a matrix comprising an inner porous core and outer porous lid surrounding said core.
    Type: Application
    Filed: April 4, 2016
    Publication date: May 10, 2018
    Applicant: GE Healthcare Bioprocess R&D AB
    Inventors: Martin Hall, Karolina Busson, Jean-Luc Maloisel, Helena Skoglar
  • SEPARATION MATRICES FOR PURIFICATION OF BIOLOGICAL PARTICLES
    Publication number: 20160367966
    Abstract: The invention discloses a separation matrix for purification of biological particles, comprising a plurality of particles having a porous core entity and a porous shell entity covering the core entity, wherein the core entity comprises at least 50 micromole/ml primary amines present on covalently attached ligands displaying at least two primary amines per ligand and the shell entity comprises less than 20 micromole/ml primary amines The invention further discloses a method of purifying biological particles and a method of manufacturing a separation matrix.
    Type: Application
    Filed: February 18, 2015
    Publication date: December 22, 2016
    Inventors: Jean-Luc Maloisel, Karolina Busson, Karol Lacki, Bjorn Noren, Helena Skoglar